» Articles » PMID: 35267517

A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Mar 10
PMID 35267517
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: The heritability of breast cancer is partly explained but much of the genetic contribution remains to be identified. Haplotypes are often used as markers of ethnicity as they are preserved through generations. We have previously demonstrated that haplotype analysis, in addition to standard SNP association studies, could give novel and more detailed information on genetic cancer susceptibility. (2) Methods: In order to examine the association of a SNP or a haplotype to breast cancer risk, we performed a genome wide haplotype association study, using sliding window analysis of window sizes 1−25 and 50 SNPs, in 3200 Swedish breast cancer cases and 5021 controls. (3) Results: We identified a novel breast cancer susceptibility locus in 8p21.1 (OR 2.08; p 3.92 × 10−8), confirmed three known loci in 10q26.13, 11q13.3, 16q12.1-2 and further identified novel subloci within these three loci. Altogether 76 risk SNPs, 3302 risk haplotypes of window size 2−25 and 113 risk haplotypes of window size 50 at p < 5 × 10−8 on chromosomes 8, 10, 11 and 16 were identified. In the known loci haplotype analysis reached an OR of 1.48 in overall breast cancer and in familial cases OR 1.68. (4) Conclusions: Analyzing haplotypes, rather than single variants, could detect novel susceptibility loci even in small study populations but the method requires a fairly homogenous study population.

Citing Articles

A GWAS Suggesting Genetic Modifiers to Increase the Risk of Colorectal Cancer from Antibiotic Use.

Vermani L, Wolk A, Lindblom A Cancers (Basel). 2025; 17(1.

PMID: 39796643 PMC: 11718953. DOI: 10.3390/cancers17010012.


Swedish Genome-Wide Haplotype Association Analysis Suggests Breast Cancer Loci with Varying Risk-Modifying Effects.

Vermani L, Barnekow E, Liu W, Wendt C, Hall P, Margolin S Genes (Basel). 2025; 15(12.

PMID: 39766883 PMC: 11675172. DOI: 10.3390/genes15121616.


Lower mRNA Expression and Higher Levels of in HER2-Positive Breast Cancer.

Dix-Peek T, Dickens C, Valcarcel J, Duarte R Biology (Basel). 2024; 13(11).

PMID: 39596875 PMC: 11591975. DOI: 10.3390/biology13110920.


Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance.

Thomsen H, Chattopadhyay S, Weinhold N, Vodicka P, Vodickova L, Hoffmann P Blood Cancer J. 2024; 14(1):140.

PMID: 39164264 PMC: 11335940. DOI: 10.1038/s41408-024-01121-8.


A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31.

Barnekow E, Hasslow J, Liu W, Bryant P, Thutkawkorapin J, Wendt C Int J Mol Sci. 2023; 24(5).

PMID: 36901898 PMC: 10003706. DOI: 10.3390/ijms24054468.

References
1.
Amos C, Dennis J, Wang Z, Byun J, Schumacher F, Gayther S . The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers. Cancer Epidemiol Biomarkers Prev. 2016; 26(1):126-135. PMC: 5224974. DOI: 10.1158/1055-9965.EPI-16-0106. View

2.
Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M . ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 2006; 38(8):873-5. DOI: 10.1038/ng1837. View

3.
Li Q, Yu K . Improved correction for population stratification in genome-wide association studies by identifying hidden population structures. Genet Epidemiol. 2007; 32(3):215-26. DOI: 10.1002/gepi.20296. View

4.
Hunter D, Kraft P, Jacobs K, Cox D, Yeager M, Hankinson S . A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007; 39(7):870-4. PMC: 3493132. DOI: 10.1038/ng2075. View

5.
Bergman A, Einbeigi Z, Olofsson U, Taib Z, Wallgren A, Karlsson P . The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. Eur J Hum Genet. 2002; 9(10):787-93. DOI: 10.1038/sj.ejhg.5200704. View